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Abstract
Regular plasma HIV-RNA testing for persons living with HIV on antiretroviral therapy (ART)
is now the global standard, but as many as 60% of persons in Africa today on ART do not
have access to standard laboratory HIV-RNA assays. As a result, patients in Zambia often
receive treatment without any means of determining true virologic failure, which poses a risk
of premature switch of ART regimens and widespread HIV drug resistance. Dry blood spots
(DBS) on the other hand require unskilled personnel and less complex storage supply chain
so are ideal to capture viral-load results from HIV patients outside clinic settings. We assess
collection of DBS in the community using non-medically trained personnel (NMP) and docu-
mented challenges. We trained 23 NMP to collect DBS from lost to follow-up (LTFU)
patients in 4 rural and urban Zambian districts. We developed a phlebotomy box to transport
DBS without contamination at ambient temperature and concomitant training and standard
operating procedures. We evaluated this through field observations, bi-weekly meetings,
reports, and staff meetings. The laboratory assessed DBS quality for testing validity. We
attempted to collect DBS from 357 participants in the community. Though individual reasons
for refusal from the remaining 37% were not collected, NMPs reported privacy concerns,
awkward box-size which drew attention in the community and fears of undisclosed uses of
samples related to witchcraft and circulating narratives about past research. Successful
DBS collection was not associated with patient gender, age, time on ART, enrolment CD4,
facility. DBS viral-load collection by NMP is feasible in Zambia. Our training approach and
assessments of NMP not part of the health system can be extended to patients by giving
them more responsibility to manage their own differentiated care groups. Concerted efforts
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that compare collection of DBS by NMP to those collected by skilled-medical personnel are
needed.
Introduction
Although there is consensus that HIV RNA monitoring is the preferred approach to monitor-
ing HIV treatment, [1–8] access to the expensive and technically demanding test remains lim-
ited in sub-Saharan Africa [6,9–12]. It is estimated that only 60% of all people living with HIV
in Africa have access to standard plasma HIV RNA testing, leading to substantial risks of
unmeasured virologic failure from HIV treatment, and HIV drug resistance (HIVDR) in the
region [10,11,13,14]. Collection of blood plasma through venepuncture, required for standard
VL monitoring is particularly difficult in decentralized settings due to training, transport costs
to laboratory facilities, and complexity in shipping and storage requirements [4,15]. Access to
VL monitoring is difficult though there are 450 laboratories across the 10 provinces in Zambia,
however capacity to conduct VL assays is limited to provincial level hospitals only (1 per prov-
ince). Zambia’s 2017 adoption of treatment guidelines in which all people living with HIV are
eligible for treatment, combined with the UNAIDS goal of 90% viral suppression, has further
increased demand for viral load testing. Furthermore, care in Zambia is increasingly being
delivered outside of clinics and in the community which introduces further challenges for tra-
ditional plasma viral load testing [16].
Dried blood spots (DBS) on the other hand, can overcome some of these requirements and
help make HIV RNA monitoring more widely accessible. Although as compared to standard
plasma HIV RNA quantification, DBS-based results are less sensitive or specific to viremia.
The consequence of misclassification can be ameliorated with different cut-points, and DBS
remains a viable means of monitoring treatment success when standard assays cannot be car-
ried out. The public health community needs more information, however, about the promising
operational characteristics to understand how best to incorporate this technology into decen-
tralized health systems. With DBS, theoretically, trained NMP can collect the sample in a
patient’s comfort obviating the need to travel to a facility for phlebotomy. [11,17]. Most of the
data about DBS to date, is focused on laboratory performance characteristics (e.g., sensitivity
and specificity) and DBS have already been shown to be a viable alternative to blood plasma
venepuncture for Polymerase Chain Reaction (PCR) in early infant diagnosis of HIV-1 infec-
tion [18,19].
In order to close this knowledge gap about implementation, we sought to evaluate the abil-
ity of NMP in collecting DBS from HIV infected persons in Zambia under routine health ser-
vice delivery conditions. We sought to assess the implementability of DBS collection in the
field using a minimally invasive collection method that could be consistently and easily imple-
mented in the community using unobtrusive NMP. We assessed our DBS collection training
for NMP, the feasibility and acceptability among beneficiaries and among NMP and predictors
of successful DBS sample collection by NMP in field conditions.
Materials and methods
Study population and setting
Between September 2015 and July 2016, 23 non-medically trained personnel were recruited
and trained to collect DBS from HIV-1- infected adults on ART identified as lost to follow up
(LTFU) from HIV care, defined as 90 or more days late for their last appointment in Zambia’s
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electronic medical record (EMR) from 13 health facilities in Lusaka Province [20,21]. Collect-
ing DBS in the field for HIV RNA quantification was carried out as part of a larger parent
study [20,21] to estimate the prevalence of viremia after accounting for normally unmeasured
LTFU patients. NMP were recruited on the basis of having higher secondary education, excel-
lent communication with interpersonal skills and ability to work confidentially with sensitive
information. The 13 clinics received technical support from the Centre for Infectious Disease
Research in Zambia (CIDRZ). CIDRZ has since 2004 supported the roll out of PEPFAR-sup-
ported National ART services in 4 provinces with over 165,000 individuals on ART having
made at least one visit two years before the project [20].
Procedures and measurements. NMP were trained to identify eligible participants,
obtain consent, collect DBS specimens and process samples (e.g., labelling, transport). We col-
lected participant demographics, clinical history, and ART adherence data. ART history, includ-
ing date of ART initiation, and WHO clinical stage, was abstracted from patient clinic records.
Sample collection procedures and transport. We engaged in a systematic process to
develop our approach to community-based DBS collection by conducting multiple interviews
and observations of an on-going study within CIDRZ to adapt steps in DBS collection that
ensure effective sample storage, transportation and quality. Interviews with facility-based staff,
laboratory and fleet personnel to determine inputs needed for effective field DBS collection
were conducted. We assessed barriers experienced during blood collection, the facilitators
identified, and recommendations for improved service delivery. We conducted web-based
searches on guidelines for DBS collection and interacted with other CIDRZ study personnel to
understand how they collected DBS from infants in the community. Web based searches
included the following terms; ((dried or dry) and blood and spot�), (DB for HIV monitoring),
(DBS and viral load and HIV), (finger prick blood sample collection in the community) and
(task shifting viral load monitoring to community health workers). Finally, we visited various
medical equipment suppliers in Zambia to source suitable lightweight phlebotomy boxes that
could be used for field collection. This process informed the design of a simplified transporta-
tion and storage system to transfer DBS from the community to the laboratory and facility.
Capillary blood was collected on Whatman grade 903 filter paper by NMP who had completed
practical and didactic training per study protocol. After collection, we air-dried DBS speci-
mens through placing them in a transportable drying rack in the field where specimens were
pinned to Styrofoam in our phlebotomy box to retain a horizontal position that did not touch
other surfaces. DBS were transported to the nearest health facility using a study motorbike fit-
ted with a carrier to keep the phlebotomy box used for DBS collection and transportation
upright at all times. Once at the facility, the DBS card was air dried for a further 4 hours
(though preferably overnight) prior to being placed in a zip lock plastic bag with a desiccant
and transported to the laboratory within 14 days of collection using a routine carrier.
To assess implementation, we captured information about completion of selected steps in
this process. DBS field collection competency was assessed by the study Quality Assurance and
Quality Control team (QA-QC) using a 14-question checklist (S1 Appendix). This tool identi-
fied key areas for booster training. Booster training: (1) reinforced specific aspects of in-person
training and (2) provided additional training on new issues encountered in the field. Our ques-
tion checklist focused on assessments of sample collection procedures (ensuring a participant’s
hands were warmed, use of alcohol swabs, correct use of requisition form, disposal of sharps,
packaging of DBS), sample quality, patient engagement and consent in the study. It was devel-
oped using available online resources and the topics covered in the DBS training package.
Each NMP was observed at least once during the study period.
Didactic and practical training. We used competency-based training for NMP and in-
service booster training. Training on DBS collection was provided by an experienced trainer
Dried blood spots collection by non-medically trained personnel
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and included a half day didactic presentation and another half day demonstration of DBS col-
lection and transportation from community to central laboratory. Additional training
included a half-day skills development/ practice session for small classes of four NMP, making
observations of competency in specimen collection. Results from observations of role plays of
DBS collection and a written in class assessment on principles of correct DBS collection were
used to provide targeted individual training. The class competency assessment tool is pre-
sented in supplementary materials (S2 Appendix). NMP were trained to air dry DBS for 4
hours (though preferably overnight) prior to being placed in a zip lock plastic bag and trans-
ported at ambient temperature to the CIDRZ central laboratory in Lusaka within 14 days of
collection using a routine transport courier (S3 Appendix). NMPs assessed the samples for
quality to ensure that blood spots 1) filled the predetermined circle on the filter paper; 2) ade-
quately soaked through to have similar size on both sides of the filter paper to rule out smear-
ing from finger contact on the collection paper; and, 3) did not overlap with one another. DBS
samples were collected between October 2015 and May 2016.
DBS sample quality and challenges. The COBAS1 AmpliPrep/COBAS1 TaqMan1
HIV-1 Test, v2.0 was used for the quantification of Human Immunodeficiency Virus Type 1
(HIV-1) RNA in DBS. The results from the VL DBS testing are reported by Sikazwe et al.
where sensitivity and specificity to detect treatment failure (threshold of 1000 copies/mL) from
DBS were determined to be 80.8% and 87.3% respectively [21]. Trained laboratory staff pro-
vided qualitative feedback on specimens collected on a bi weekly basis. DBS quality was
assessed by examining the adequacy of drying before being packaged to the laboratory, absence
of clotting, sufficient blood spot and accurate labelling of sample as per laboratory standards.
We conducted bi-weekly staff meetings with NMP and discussed the challenges faced in the
DBS collection component of the study such as community/ participant reactions to DBS col-
lection. Four Focus Group Discussions (FGDs) of 5–6 NMP purposively selected for their role
in DBS collection were also conducted once during study implementation and then at the end
of the study. Discussions notes were taken for transcription and thematic analysis. The FGD
question guide was developed in response to the experiences reported from individuals during
study implementation. In each FGD, we discussed challenges during DBS collection in the
field, both practical and socio-cultural.
Analysis
FGDs were not audio recorded hence detailed field notes were used as part of our summary
process, to articulate our interpretations of the data from the FGDs. Our analysis sought rela-
tionships between various themes that were identified during discussions with the NMP by con-
stant comparative analysis. Descriptive statistics on the competency test and field evaluation
performance were used to summarize NMP understanding of processes. Bivariate and multi-
level mixed effects logistic regression models were used to assess factors associated with success-
ful DBS collection (suitable for testing by the laboratory). Sociodemographic information on
samples was collected from the Laboratory Information Management System (LIMS) and EMR.
Sex, age, years on ART, and evidence of CD4 count and facility type were used in the model.
Ethics
Ethical approval was obtained from the University of Zambia Biomedical Research Ethics
Committee (UNZABREC), University of Alabama at Birmingham (UAB) institutional review
boards (IRB) and Ministry of Health (MOH) prior to initiating study procedures. All partici-
pants provided written informed consent which was recorded on the consent form. All IRBs
approved this consent procedure.
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Results
Blood collection
The parent study identified 357 LTFU individuals from EMR as eligible for DBS to assess viro-
logic suppression. Just over 40% were male, median age of 36 (IQR: 30–41) with a median
enrolment CD4 count of 248 cells/μL (IQR: 131–391). Demographic and clinical characteris-
tics of this population are described in Table 1. We successfully determined the whereabouts
of all 357 LTFU individuals for whom blood draw was successful for 197 participants (Fig 1A).
No blood was collected from 132 (37%). Of those, the vast majority or 123 (93%) refused blood
draws, 7 (1.9%) were out of town or dead, and 1 (0.3%) had fingers too callused for DBS collec-
tion. Fig 1B shows that patient engagement had the most influence for successful DBS collec-
tion. Our bivariate and multivariate logistic regression model for predictors of successful DBS
collection did not yield any significant associations with patient gender, age, time on ART,
enrolment CD4 nor facility type.
Competency of non-medical personnel
All 23 NMP passed and completed the competency test with an average score of 86% (Fig 2.).
Competency test scores were calculated as a percentage of correct responses out of total ques-
tions asked. NMP were evaluated in the field at least once and combined with laboratory
Table 1. Characteristics of all patients eligible for DBS between 19 October 2016 and 31 May 2017, N = 357.
BASELINE CHARACTERISTICS N = 357
Male Sex, n (%) 153 (41)
Median Age, years (IQR) 36 (30–41)
Time on ART, years (IQR) 1.3 (0.33–3.53)
Enrolment CD4 count, cells/μL (IQR) 248 (131–391)
WHO clinic stage at initiation, n (%)
Stage 1 166 (49)
Stage 2 55 (16)
Stage 3 105 (31)
Stage 4 12 (2.6)
Prior History of TB, n (%) 238 (63.6)
Marital Status, n (%)
Single 64 (18)
Married 233 (64)
Divorced 36 (10)
Widowed 31 (9)
Highest Education, n (%)
None 9 (2.5)
Lower mid-basic 129 (35)
Upper basic/secondary 166 (45)
College/ University 61 (17)
Facility type, n (%)
Hospital 45 (12)
Rural 38 (10)
Urban 291 (78)
Values are N (%) or median, interquartile range (IQR). ART, Antiretroviral therapy; WHO, World Health
Organization; TB, Tuberculosis
https://doi.org/10.1371/journal.pone.0223573.t001
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reports of insufficient or poor-quality samples, 9 received targeted booster training on topics
ranging from collection and drying of DBS, packaging of DBS and procedure for needle stick
injury. Common problems discussed during bi-weekly feedback meetings included challenges
in sample collection based on competency results, privacy during blood collection and partici-
pant acceptance of blood collection.
Fig 1. DBS study population and collection cascade. (A) Flow diagram of enrolment and DBS follow-up (B) DBS collection cascade. LTFU, lost to follow-up; DBS,
Dried Blood Spot; LIMS, Laboratory Information Management System. Data shown is from 13 study sites.
https://doi.org/10.1371/journal.pone.0223573.g001
Fig 2. Competency test scores for trained non-medical personnel. Test scores assessed understanding of materials required for dried blood spot (DBS) collection,
collection procedures and air drying for finger prick DBS, packaging and transportation of DBS and response to needle stick injury.
https://doi.org/10.1371/journal.pone.0223573.g002
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Laboratory assessment
Fig 1 shows that 28 (8%) of the 357 eligible for DBS were rejected by the laboratory due to
inappropriate labelling (mismatch between the patient ID from the facility EMR and LIMS).
In total, 197 DBS samples, were successfully collected for viral load testing. The laboratory suc-
cessfully tested 98% (N = 195) of DBS samples. 1% (N = 2) of the 197 contained insufficient
blood when assessed by the laboratory and were therefore rejected. Detailed results on how we
managed bias incurred via the inaccuracy of DBS-based viral load results by using the docu-
mented sensitivity of 80.8% and specificity of 87.3% (for detecting a viral load of� 1,000 cop-
ies/ml) as compared to plasma HIV RNA determination through an outcome misclassification
correction approach are provided in Sikazwe et al [21].
Qualitative findings of DBS collection
Table 2 shows the sample DBS questions for FGDs. Overall, NMP reported enthusiasm for
DBS collection among patients in bi-weekly meetings and the FGDs conducted at the begin-
ning and end of tracing. In the four FGDs with 23 NMP, a high frequency revealed that partici-
pants wanted more control over their health and were interested in the DBS collection process,
saying that “In the field, patients want [VL] results [from DBS collection] then and there.”
However, NMP also discussed environmental and social constraints to patient privacy and
confidentiality.
Lack of privacy. At the first meeting, it was often difficult to find a private place where
nobody could witness the process of finger prick and blood spotting such that “sometimes you
have to assess a patients’ home and maybe come back” and that “Some patients opt for clinic-
based DBS collection”.
NMP were unable to freely interview and collect DBS samples for some participants
because of home environments that lacked privacy from other family members. Due to stigma,
it is common for HIV-infected LTFU participants to not disclose their status to other family
members or work colleagues[22,23]; hence appointments were made to meet with participants
willing to take part in the study at a time or place when privacy was assured (Table 3).
Our NMP initially traced patients without the phlebotomy box so as to protect the privacy
of individuals due to suspicion it raises among other community members. Once they identi-
fied the patient and explained the process, they returned with their phlebotomy box to collect
the DBS sample, which was not always well received (Table 3).
Lack of confidentiality and associated stigma. Even if privacy was assured regardless of
wanting to collect DBS, there was no guarantee that interviews would not be overheard within
the home. NMP assessed the physical environment where they met with the participant and in
most cases, would follow the participant’s lead on whether a particular environment was suit-
able. If the participant determined it unsuitable, the NMP asked for suitable alternatives.
Table 2. Sample questions for Focus Group Discussions with NMPs.
Question
1) Describe your experience of collecting DBS in the community
2) Describe the response from the community
3) Why do patients accept DBS collection
4) What are the main reasons for a patient refusing DBS collection
5) Do patients understand the importance of Viral Load
NMP, non-medical personnel; DBS, dried blood spots
https://doi.org/10.1371/journal.pone.0223573.t002
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Study NMP found that participants had disclosure concerns due to poor experiences with
health workers telling other community members about their HIV status [22–24]. According
to our study NMP, this affected the welcome NMP received in communities where they were
perceived to be health care workers.
Study NMP also described how clinic staff contribute to stigma in the community by not
maintaining confidentiality and disclosing who is living with HIV. NMP reported multiple
issues related to disclosure the can arise in the community setting, including fear of direct dis-
closure by staff and fear of disclosure by association with the clinic (Table 3). Fear of rumours
starting about the community-based blood collection also affected recruitment of study partic-
ipants, and the relationship between the NMP/researchers and the study sample. They
described stigma by way of disclosure concerns and public attitude as the main reason for
refusing blood collection, fearing for example that people “would say why that house . . .”. The
study addressed this by ensuring staff did not wear identifiable clothes and strictly adhering to
agreed appointments for blood collection.
Discussion
Our findings suggest that it is feasible to train and support NMP to competently collect finger
prick DBS samples for viral load testing under field conditions and in areas which cannot be
served by standard laboratory networks in sub-Saharan Africa [11,17,25,26]. The provision of
free ART services regardless of CD4 count in Zambia has created unprecedented health sys-
tems demand that cannot be met using traditional viral load monitoring techniques that
require a lot of infrastructure and utilization of highly skilled personnel [25,27,28]. With all
but 2 samples viable for VL analysis and over 90% clearly linked to specific individuals, we
have successfully shown that DBS collection by NMP allows us to monitor VL collected in the
community. The mismatching of 28 samples was due to the failure of the healthcare system in
maintaining unique patient identifiers in the EMR at the facility and LIMS [29].
Overall, this paper provides a detailed description of the operational challenges associated
with collecting DBS in the field and suggest that this approach should be incorporated in set-
tings where plasma viral load monitoring is not feasible, including in treatment models that
are predominantly or mostly community based. We found the largest drop off to be related to
patient refusal. While we did not collect reasons for refusal, the population which we sought
were patients who had been LTFU, who have a high prevalence of stigma and other barriers to
treatment[30,31]. In contrast, if the patients agreed, very few failures at the collection process,
transport, labelling, nor laboratory testing would have occurred. Indeed, the operational chal-
lenges are mostly patient-based, whereas the technical dimensions occurred smoothly. In
short, where health systems need to collect DBS in the field, patient engagement had the great-
est influence on success. Our results show that NMPs can be used to improve access to VL
Table 3. Qualitative results from DBS collection experience.
Theme Quote
Privacy “We had to make appointments because when we went with the box, people would run
away. . .we needed a smaller DBS box”
“The issue with DBS is privacy. People were suspicious even of rucksacks”
“The size of the bag triggers suspicion. A change in bags is necessary. . .”
Stigma and
Confidentiality
“They have a problem with the staff. Sometimes Health Care Workers (HCW) expose
patients in the community. . .very common for that clinic”
DBS, dried blood spots
https://doi.org/10.1371/journal.pone.0223573.t003
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monitoring in remote settings. A detailed understanding of how the contextual challenges
faced not only by NMPs but also patients in the community can help strengthen DBS VL mon-
itoring. However there is a broad consensus about the ability to enhance delivery of basic ser-
vices to child care-takers (maternal, child and women’s health [MCH] interventions) and ART
patients using community health workers therefore leading to improvements in mortality
[32]. It is true that these improvements are not the case in all settings and implementing pro-
grammes using NMP has been a challenge but the benefits still outweigh the disadvantages. In
our setting, non clinical personal are often associated with HIV care follow up, for example
LTFU tracing [20,21]. As this was a research study that encouraged patient confidentiality, it is
likely that uptake of DBS VL in the community can be increased through sensitization through
key health promotional messages in larger public health programmes and also by receiving
supervisory support from professional health care workers at the facility to ensure quality by
alignment to the broader health system.
With an average competency score of 86%, our ability to competently train NMP has the
potential to expand differentiated services without overly straining finances by task shifting
highly skilled processes to less skilled personnel as has been done in Zambia and others by use
of lay health care workers in response to the human resource demands of HIV care and treat-
ment [27,33,34]. NMP were recruited from populations similar to people living with HIV
(PLHIV) i.e. non-medically trained, meaning that it may be possible to empower patients to
collect DBS VL samples within their own differentiated community adherence groups. This
would further reduce the need for routine clinic/ laboratory visits which are costly and over-
burden both patients and facilities, releasing staff to pay closer attention to patients with
unsuppressed VL [16,27,35]. This represents an important element of health systems strength-
ening, especially insofar as many countries in Sub-Saharan Africa (SSA) are implementing test
and treat all and VL testing without sufficient and sophisticated equipment and skilled person-
nel [1,28,36,37], suggesting that VL implementation currently falls well short of guidelines and
limits the public health impact of programmes.
Although NMPs reported a desire by patients to have blood drawn by DBS, disregard for
patient confidentiality and professionalism by health care workers who work and reside in the
same community as participants must be addressed to regain public trust [23]. The collection
of DBS by NMPs in the community was potentially hindered by the poor patient experience
with health care workers at the facility and in the community, resulting in patients disengaging
from healthcare services [31,38–41]. Based on the findings from our study staff, measures to
protect patient confidentiality such as the use of much smaller boxes concealed in a gym bag
and identifying community spaces such as schools and churches where privacy and confidenti-
ality can be maintained could increase uptake. Adopting a three-pronged approach of training,
mentorship, and continuous quality assessment could allow for the rapid roll-out of VL moni-
toring by NMP in resource limited settings.
Conclusions
This is the first study to describe the processes of developing and implementing DBS collection
by non-medically trained personnel in field conditions. Use of NMP can serve as an important
catalyst in promoting adoption of VL, ensuring better patient outcomes, and enabling vulnera-
ble patient groups and those in rural areas to be reached more effectively. The collection of
DBS also shows promise for field-based collection including by HIV patients themselves in dif-
ferentiated service delivery models, which would reduce travel costs for patients, decongest
facilities and for national HIVDR surveillance. Identification of community spaces to ensure
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privacy and confidentiality along with structured programmes for stigma reduction could
increase participation in community-based DBS collection.
Limitations
Our study should be considered with the following limitations. Just over a third of our sample
(37%) refused DBS collection, and our NMPs uncovered fears of lack of privacy and confi-
dentiality, perceived stigma, and dislike of unnecessary procedures, all of which can be
addressed albeit with considerable effort to minimize the size of the box (S3 Appendix)
[42,43]. Of note, the study population is one that previously disengaged from HIV care pro-
vided by medically trained personell. We believe the refusal rate observed in this study is indic-
ative of perceived benefit and trustworthiness in interactions between systems, individuals and
patients. We recruited NMP who were familiar with the communities in which the facilities
were based. Successful DBS collection by NMP relies on the elevated level of group participa-
tion and beneficial links between NMP and the health system. Because of this, the role that
trust plays in the work on NMP could have been underestimated [32]. Despite these chal-
lenges, we believe there are important lessons that come out of our experience collecting DBS
in the community.
Our findings are based on a review of implementation documents and rapid data collection
by QA-QC and study managers to make mid-course corrections in procedures. Careful con-
sideration will need to be given to ensuring quality control and performing cost-effectiveness
analysis on costs associated with training and supporting DBS collection. This study was based
on a cohort of LTFU patients who behave differently to patients engaged in HIV care. Our
FGDs were not audio recorded, however detailed notes were taken.
Implications
The ease of collecting and transporting DBS is invaluable given that current laboratory infra-
structure and the relative complexity of techniques preclude decentralization of VL and
HIVDR testing beyond second tier referral laboratories. DBS collection by NMP is potentially
suitable to use in community-based settings. A WHO survey in low and middle-income coun-
tries found that only 60% of patients on ART receive VL testing with the demand for VL test-
ing in Africa having reached 9.5 million in 2018. Task shifting to NMP to collect DBS would
mean patients on ART could be monitored regularly for VL and HIVDR so that their ART reg-
imen can be modified according to their resistance profile. DBS collection that is logistically
feasible, cost saving and responsive to patient demand, therefore has a critical role in health
systems innovating to attain the 90-90-90 targets [1,8,17]. The ability to collect DBS in non-
clinical settings makes it a realistic routine component of care, especially in differentiated ser-
vice delivery settings where patients might meet in schools and other community settings and
receive services such as adherence counselling and ART drug delivery [44].
Supporting information
S1 Appendix. 14-question field checklist. Questions used to assess field implementation of
dried blood spot collection by non-medical personnel.
(PDF)
S2 Appendix. Competency assessment tool. Assessment tool used to assess knowledge of
dried blood spot (DBS) collection procedures by non-medical personnel post didactic and
practical training.
(PDF)
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S3 Appendix. DBS collection box with partitioning. Modified first aid box partitioned with
Styrofoam to hold dired blood spots (DBS) horizontally at all times during transportation.
(TIFF)
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